Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1

Interventions

Specimen Handling 136Magnetic Resonance Spectroscopy 110Biopsy 82pembrolizumab 64Nivolumab 59Carboplatin 59Cyclophosphamide 55Cisplatin 53Paclitaxel 46Gemcitabine 39Bevacizumab 39Radiotherapy 36Dexamethasone 34Doxorubicin 28atezolizumab 27Rituximab 27olaparib 25durvalumab 25venetoclax 24Pemetrexed 24Fluorouracil 24Cytarabine 24fludarabine 22Vincristine 22Prednisone 22Lenalidomide 22Injections 22Immunoglobulin G 22130-nm albumin-bound paclitaxel 22X-Rays 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Laryngectomy × 30 days × Clear all
NCT07392580 2026-06-01

Intralesional Chemotherapy (IC): Cisplatin + Epinephrine

University of Miami

Phase 2 Recruiting
20 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡